| Authors: |
Timerman D; Harvard-MIT Health Sciences and Technology (HST), Harvard Medical School, Boston, MA, USA., McEnery-Stonelake M; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA., Joyce CJ; Department of Biostatistics, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA., Nambudiri VE; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Hodi FS; Melanoma Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Claus EB; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA., Ibrahim N; Melanoma Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Merck Research Laboratories, Clinical Oncology, North Wales, PA, USA., Lin JY; Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Melanoma Program, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. |
